DERIVATIVE LIABILITY - Additional Information (Detail) (USD $)	1 Months Ended	3 Months Ended	6 Months Ended	12 Months Ended		1 Months Ended
	Oct. 21, 2011	Sep. 30, 2012	Sep. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 09, 2011 Patent (U.S. No. 6,475,531 B1)	Feb. 28, 2011 Patent (U.S. No. 6,475,531 B1) L.Y. Hong Kong Biotech Limited	Feb. 28, 2011 Patent (U.S. No. 6,475,531 B1) L.Y. Hong Kong Biotech Limited Minimum	Feb. 28, 2011 Patent (U.S. No. 6,475,531 B1) L.Y. Hong Kong Biotech Limited Scenario 1	Feb. 28, 2011 Patent (U.S. No. 6,475,531 B1) L.Y. Hong Kong Biotech Limited Scenario 2
Fair Value of Financial Instruments [Line Items]
Common stock shares issued to acquire patent							44,254,952
Common stock, shares issuable							31,610,544		11,063,968	20,546,711
Minimum Proceeds from issuance of debt and/or equity in order to issue shares to sellers of patent						$ 20,000,000		$ 20,000,000
Agreement cancellation period	1 year
Number of shares issued	55,318,920
Number of shares to be repurchased	55,318,920		55,318,920
Fair value of price per share	$ 0.40		$ 0.02
Stock restriction period	1 year
Percentage of shares to be repurchased		100.00%	100.00%	100.00%	15.00%
Derivative liability		$ 1,106,378	$ 1,106,378	$ 5,531,892	$ 3,319,135
Agreement expiration date		Oct. 21, 2012		Oct. 21, 2012